Literature DB >> 20368825

Three cases of synchronous solid tumor and multiple myeloma.

Sang Hoon Ji1, Joon Oh Park, Jeeyun Lee, Mi Jung Oh, Do Hyoung Lim, Byeong-Bae Park, Keun Woo Park, Se-Hoon Lee, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H Lee, Keunchil Park.   

Abstract

The association between a multiple myeloma and a secondary solid tumor is not well established. Some reports showed an increased risk of secondary solid neoplasms in multiple myeloma patients, but others have not. Three cases of the synchronous occurrence of multiple myelomas and solid tumors, namely, a small cell carcinoma of the lung, an adenocarcinoma of the colon and a squamous carcinoma of the pyriform sinus were experienced at our hospital. Therefore, herein is reported the clinical courses and treatment results. The stage of multiple myeloma was Durie-Salmon stage I in all of three cases; therefore, the solid tumors were treated as a primary target because the prognosis of early stage multiple myeloma is generally better than that of advanced solid tumor, while a smoldering or stage I myeloma do not need primary therapy until progression of the multiple myeloma. Two patients died of their solid tumors, but one patient is alive.

Entities:  

Keywords:  Multiple myeloma; Second neoplasm; Synchronous neoplasm

Year:  2004        PMID: 20368825      PMCID: PMC2843872          DOI: 10.4143/crt.2004.36.5.338

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  11 in total

1.  Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma.

Authors:  K Oshima; Y Kanda; Y Nannya; M Kaneko; T Hamaki; M Suguro; R Yamamoto; A Chizuka; T Matsuyama; N Takezako; A Miwa; A Togawa; H Niino; M Nasu; K Saito; T Morita
Journal:  Am J Hematol       Date:  2001-05       Impact factor: 10.047

2.  Multiple myeloma and acute myelomonocytic leukemia.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

3.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

4.  Patients with multiple myeloma and solid tumors: six case reports.

Authors:  L Christou; S Tsiara; Y Frangides; J Pnevmatikos; E Briasoulis; E Galanakis; K L Bourantas
Journal:  J Exp Clin Cancer Res       Date:  1998-06

Review 5.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

6.  Second malignancies in patients with multiple myeloma.

Authors:  I P Law; J Blom
Journal:  Oncology       Date:  1977       Impact factor: 2.935

7.  Solid tumors in multiple myeloma.

Authors:  R Stegman; R Alexanian
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

8.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

Review 9.  Multiple myeloma.

Authors:  Bhawna Sirohi; Ray Powles
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

10.  Changing clinical presentation of multiple myeloma.

Authors:  A Riccardi; P G Gobbi; G Ucci; D Bertoloni; R Luoni; L Rutigliano; E Ascari
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

View more
  5 in total

1.  Simultaneous multiple myeloma and non-small cell lung carcinoma: A case report and review of the literature.

Authors:  Huan-Huan Dong; Jing Li; Lin Kang; Qiang Wei; Yan Li
Journal:  Oncol Lett       Date:  2022-05-03       Impact factor: 3.111

2.  Multiple myeloma emerging after prolonged gefitinib treatment for non-small cell lung carcinoma.

Authors:  Sian Yik Lim; Sachiko Ando; Kaoru Nishiyama; Simi Padival
Journal:  Case Rep Oncol       Date:  2011-04-06

3.  Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report.

Authors:  Wenli Zuo; Xinghu Zhu; Jingke Yang; Zhenyang Mei; Mei Deng; Quande Lin; Yongping Song; Qingsong Yin
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  Rapid progression of gastric cancer with liver metastasis after discontinuation of lenalidomide in a patient with concurrent multiple myeloma: A case report.

Authors:  Naoto Ujiie; Yoshitaka Enomoto; Naruhito Takido; Yasushi Kawaharada; Masashi Zuguchi; Yosuke Kubota
Journal:  Int J Surg Case Rep       Date:  2021-03-26

5.  A Case of Multiple Myeloma Following Bladder Cancer.

Authors:  Hamid Shafi; Mohsen Vakili Sadeghi; Hosein Ghorbani; Majid Sharbatdaran
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.